Evidence map›Paper›PMID 38543971›Full record

ArticleVaccines2024

National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia.

Maarten Jansen, Dijana Spasenoska, Mardiati Nadjib, Desalegn Ararso, Raymond Hutubessy, Anna-Lea Kahn, Philipp Lambach

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maarten JansenImmunization, Vaccines and Biologicals Department, World Health Organization, 1202 Geneva, Switzerland.
Dijana SpasenoskaDepartment of Social Policy, London School of Economics and Political Science, London WC2A 2AE, UK.ORCID 0000-0003-3640-4405
Mardiati NadjibDepartment of Health Policy and Administration, Faculty of Public Health, Universitas Indonesia, Depok 16424, Indonesia.
Desalegn ArarsoEthiopian Public Health Institute, Addis Ababa 1242, Ethiopia.
Raymond HutubessyImmunization, Vaccines and Biologicals Department, World Health Organization, 1202 Geneva, Switzerland.
Anna-Lea KahnImmunization, Vaccines and Biologicals Department, World Health Organization, 1202 Geneva, Switzerland.ORCID 0000-0001-8565-2814
Philipp LambachImmunization, Vaccines and Biologicals Department, World Health Organization, 1202 Geneva, Switzerland.ORCID 0000-0003-0105-8899

Funding

Gates Foundation OPP1174807World Health Organization 001
6 · The paper itself

Abstract

To ensure that limited domestic resources are invested in the most effective interventions, immunization programs in low- and middle-income countries (LMICs) must prioritize a growing number of new vaccines while considering opportunities to optimize the vaccine portfolio, as well as other components of the health system. There is a strong impetus for immunization decision-making to engage and coordinate various stakeholders across the health system in prioritization. To address this, national immunization program decision-makers in LMICs collaborated with WHO to structure deliberation among stakeholders and document an evidence-based, context-specific, and transparent process for prioritization or selection among multiple vaccination products, services, or strategies. The output of this effort is the Country-led Assessment for Prioritization on Immunization (CAPACITI) decision-support tool, which supports using multiple criteria and stakeholder perspectives to evaluate trade-offs affecting health interventions, taking into account variable data quality. Here, we describe the user feedback from Indonesia and Ethiopia, two initial countries that piloted the CAPACITI decision-support tool, highlighting enabling and constraining factors. Potential immunization program benefits and lessons learned are also summarized for consideration in other settings.

Indexed as

decision-supportHTAimmunizationLMICsMCDAnew vaccine introductionpriority settingvaccine

Identifiers

PMID38543971
PMCPMC10974132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.